VSELS

Very Small Embryonic-Like Stem Cells (VSELs)

The fields of longevity and regenerative medicine are forever changed with the addition of Very Small Embryonic-Like Stem Cells (VSELS) to our list of interventions for biological rejuvenation. Orthopedic, neurological, cardiovascular, autoimmune conditions, etc... You name it, VSELS can support it.

VSELS essentially offer the ‘best of both worlds’ - they possess the pristine nature and pluripotent characteristics of young embryonic cells able to form into virtually any other type of cell in the body, minus the health risk, invasive procedures to acquire, and ethical dilemmas complicating other autologous and allogenic stem cell offerings.

In the human body, VSELS ‘go to sleep’ at birth and a critical volume is actively maintained in circulation for our emergent needs. Previously only activated under severe physiological states (hypothermia, hypoxia, tissue / organ damage), the SONG Laser and our protocols photobiomodulate platelet rich plasma, ‘awakening’ 30 - 50 million VSELS per treatment. Readministered via systemic infusions and local injections, SONG Laser-guidance further enhances deposition to key treatment areas desired.

Like other adult stem cells, VSELS can be used to treat musculoskeletal and neurological conditions. However, at 1-2 microns upon activation, nearly all VSELS avoid pulmonary capillary filtration and can achieve penetration through the Blood Brain Barrier (BBB), far surpassing previous limitations of other stem cell offerings particularly in their potential to treat brain and endocrine tissues, autoimmune conditions, post-infectious inflammatory damage and more!

Moreover, in our quest to enhance longevity, this technology not only captures the utility of 1-Day old telomerase in VSELS, it is the first to achieve an average longevity escape velocity (LEV) of 3 years biological regression from chronological age per singular systemic treatment.

Treatment cost |  $10,000+